RNFT2促进了三阴性乳腺癌的恶性病变,并预测了不良结果
Shi Tang1, Peiqi Wen2, Yuanyuan Chen2
1Department of Breast Surgery, Dongguan Maternal and Child Health Care Hospital, No. 99 Zhenxing Road, Dongcheng District, Dongguan, 523000, Guangdong, PR China. tangshits@163.com.
Journal of molecular histology
|July 9, 2025
概括
包含蛋白2 (RNFT2) 的环指跨膜域促进了三阴性乳腺癌 (TNBC) 的进展和低生存率. 针对由miR-211-5p调节的RNFT2,可能为TNBC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有有限治疗选择和高复发率的侵袭性亚型.
- 含有蛋白2 (RNFT2) 的环指跨膜域,一种E3泛素联酶,被认为是各种癌症中的瘤基因.
- RNFT2在TNBC病原体中的特定作用仍然在很大程度上未被探索.
研究的目的:
- 阐明RNFT2在三阴性乳腺癌中的功能和潜在的分子机制.
- 研究TNBC患者的RNFT2表达水平和临床结果之间的相关性.
- 探索针对RNFT2作为TNBC治疗策略的潜力.
主要方法:
- 在乳腺癌数据集中RNFT2表达的生物信息分析 (GEPIA,Kaplan-Meier绘图器).
- 在体外测试包括西部斑,qRT-PCR,CCK-8,Transwell和管形成测试,以评估RNFT2功能.
- 使用细胞衍生异种移植模型,H&E染色和免疫组织化学的体内研究.
- 机械研究涉及miRNA预测,双露西法酶记者测定和救援实验.
主要成果:
- 乳腺癌中RNFT2表达升高,在TNBC中显著过度表达,与晚期,淋巴结转移和整体生存率差相关.
- 沉默RNFT2显著抑制TNBC细胞的增殖,入侵和血管新生 in vitro和瘤生长 in vivo.
- MiR-211-5p直接针对RNFT2,对其表达产生负面调节;RNFT2的恢复可以消除miR-211-5p的抗瘤作用.
结论:
- 在三阴性乳腺癌中,RNFT2起到关键的瘤基因作用,促进瘤的进展和转移.
- RNFT2表达是预测TNBC患者不良结果的潜在生物标志物.
- miR-211-5p/RNFT2轴代表了TNBC治疗的一个有前途的治疗标.
相关概念视频
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
The Nucleolus
9.2K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.2K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Negative Regulator Molecules
36.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.1K


